PS165 Alirocumab Efficacy is Independent of Background Statin Type or Dose

Statins increase PCSK9 plasma levels, which may potentially affect alirocumab efficacy due to partial elimination via PCSK9-mediated clearance.

Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: A.L. Catapano, L.V. Lee, M.J. Louie, D. Thompson, J. Bergeron Tags: Poster Abstract Source Type: research